Additionally, the serum biomarkers fibroblast growth factor 21 (FGF21) and glutamic-oxaloacetic transaminase 1 (GOT1) were significantly up-regulated in drug induced NAFLD. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.